← All organizations
Highest phase reached
Phase 4
Timeline
2000s
- Jan 1, 2006
Pacira Pharmaceuticals— Founded
2010s
- Oct 6, 2017
triamcinolone— NDA Secondary Org
- Oct 6, 2017
triamcinolone— Marketing Organization
- Mar 5, 2019
MyoScience— Acquired
2020s
- Oct 13, 2021
Flexion Therapeutics— Acquired
Drugs by trial phase (20 distinct, 109 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (2 own, 2 via acquisition)
Phase 2 (3 own, 1 via acquisition)
Phase 1 (1 own, 2 via acquisition)
Indications
Studied for
- Agnosia
- Bunion
- Central Nervous System Neoplasms
- Contracture
- Coronary Artery Disease
- Coronary Stenosis
- Dupuytren Contracture
- Finger Injuries
- Fractures, Bone
- Genital Neoplasms, Female
- Hallux Valgus
- Hand Injuries
- Hemorrhage
- Hemorrhoids
- Hernia
- Hernia, Abdominal
- Hernia, Inguinal
- Hip Fractures
- Infertility
- Infertility, Male
- Intestinal Obstruction
- Leukemia
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Lymphoma
- Meningeal Carcinomatosis
- Meningeal Neoplasms
- Meningitis
- Mitral Valve Insufficiency
- Neoplasms
- Nervous System Neoplasms
- Postoperative Pain
- Pulmonary Disease, Chronic Obstructive
- Rotator Cuff Injuries
- Shoulder Pain
- Toothache
- Tricuspid Valve Insufficiency
- Wounds and Injuries
- Wrist Injuries
Marketed drugs (4)
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (50)
- NCT07212114CollaboratorPhase 3Oct 31, 2025
- NCT06977568Lead sponsorPhase 2Jul 25, 2025
- NCT06977568OfficialPhase 2Jul 25, 2025
- NCT06884865Lead sponsorPhase 2Feb 26, 2025
- NCT06884865OfficialPhase 2Feb 26, 2025
- NCT06350981CollaboratorPhase 2/Phase 3Apr 30, 2024
- NCT06271265Lead sponsorPhase 1Mar 29, 2024
- NCT06269705Lead sponsorPhase 3Feb 5, 2024
- NCT06269705OfficialPhase 3Feb 5, 2024
- NCT06077422CollaboratorPhase 2/Phase 3Jan 2, 2024
- NCT05456490Lead sponsorPhase 1Jan 3, 2023
- NCT05456490Study directorPhase 1Jan 3, 2023
- NCT05730920CollaboratorPhase 4Oct 19, 2022
- NCT05157841Lead sponsorPhase 3Jan 31, 2022
- NCT05139030Study directorPhase 3Jan 31, 2022
Details
- Founded
- Parsippany, NJ, US Jan 1, 2006
- Last known activity
- Oct 31, 2025